Jeff Yass’s Indivior Pharmaceuticals INDV Stock Holding History

Jeff Yass’s Portfolio INDV Stock Details INDV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$37.2M	Buy	907,300 +742,300	+450%	+$26.9M	﹤0.01%	1812
2026 Q1	$5.03M	Sell	165,000 -819,800	-83%	-$27.1M	﹤0.01%	4211
2025 Q4	$35.3M	Buy	984,800 +92,000	+10%	+$2.81M	﹤0.01%	1664
2025 Q3	$21.5M	Buy	892,800 +856,800	+2,380%	+$17.9M	﹤0.01%	2122
2025 Q2	$531K	Buy	+36,000	New	+$419K	﹤0.01%	9045
2025 Q1	–	Sell	-21,300	Closed	-$265K	–	12941
2024 Q4	$265K	Sell	21,300 -48,100	-69%	-$495K	﹤0.01%	10101
2024 Q3	$677K	Sell	69,400 -89,900	-56%	-$1.05M	﹤0.01%	7735
2024 Q2	$2.57M	Buy	+159,300	New	+$2.88M	﹤0.01%	4599

Other funds holding INDV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

OCM

Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jeff Yass's INDV Position: Q2 2026 in Review

Jeff Yass reduced its Indivior Pharmaceuticals (INDV) stake by 61% in Q2 2026, selling an estimated $3.55M and leaving 62,340 shares worth $2.56M. The position accounts for ﹤0.01% of the portfolio, ranked #5930.

Jeff Yass first reported a position in INDV in Q3 2023 and has held it in 12 quarters since. The position peaked at $21.7M in Q1 2025. 336 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

Jeff Yass held 62,340 shares of Indivior Pharmaceuticals worth $2.56M as of Q2 2026.
Jeff Yass sold 97,757 Indivior Pharmaceuticals shares in Q2 2026, an estimated $3.55M.
Indivior Pharmaceuticals made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #5930 holding.
Jeff Yass first reported a position in Indivior Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
Jeff Yass's Indivior Pharmaceuticals position peaked at $21.7M in Q1 2025.
336 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.